PROCESSA PHARMACEUTICALS INC Chart calendar Processa Pharmaceuticals Inc
0476836118035a8c24646d.lc00qhh6pHkWJS2pXCklAEH7lSHJf4a39v1tgPYiFQA.wbhO7F0y6z9wQUXfangIdxC_8hOxOsTGl5E52INWVGng-0HEcQnIJmVNbA~733ce5e4f5878398a07bdf0b1e092ada
Upcoming events on Processa Pharmaceuticals Inc
No events available
Past events on Processa Pharmaceuticals Inc
| 14/05/2024 | EF Hutton Investor Conference |
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Poster No: 23 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Poster No: 11 |
| 03/04/2024 15:55 | MedInvest Biotech & Pharma Investor Conference |
| 26/02/2024 15:00 | BIO CEO & Investor Conference |
| 20/02/2024 18:30 | Winter Wrap-Up MicroCap Rodeo Virtual Investor Conference |
| 08/01/2024 | Biotech Showcase |
| 20/12/2023 21:30 | Business Update Call |
| 05/12/2023 21:35 | MedInvest Oncology Investor Conference |
| 16/11/2023 19:40 | Paradigm Orphan Drugs & Rare Diseases Global Congress |
| 14/11/2023 18:00 | Extraordinary Shareholders Meeting |
| 19/10/2023 21:30 | ThinkEquity Conference |
| 13/09/2023 20:30 | H.C. Wainwright Global Investment Conference |
| 17/08/2023 16:30 | Sidoti Micro Cap Conference |
| 27/06/2023 17:00 | Annual General Meeting |
| 21/06/2023 17:00 | MedInvest Oncology Investor Conference |
| 24/05/2023 21:20 | World Orphan Drug Congress - Panel |
| 06/05/2023 20:00 | Digestive Disease Week |
| 30/03/2023 21:30 | Q4 2022 Earnings Call |
| 30/03/2023 21:01 | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,44 -5,62 -14.64% | -11,6 -11,5 -0.57% | -20,3 -20,8 2.6% | -11,5 -11,2 -2.63% | -11,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,4 -8,56 -80.17% | -12,0 -11,6 -2.98% | -27,4 -20,8 -32.16% | -11,1 -10,9 -2.1% | -11,0 |
|
Net income Million USD | Released Forecast Spread | -14,4 -8,20 -75.8% | -11,4 -11,4 -0.48% | -27,4 -20,8 -32.16% | -11,1 -10,9 -2.1% | -12,6 |
|
EPS USD | Released Forecast Spread | -50,8 -26,3 -93.16% | -15,0 -14,8 -1.35% | -34,0 -24,3 -39.73% | -8,48 -8,50 0.24% | -3,82 |
| Announcement Date | 25/03/21 | 30/03/22 | 30/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
|
EBIT Million USD | Released Forecast Spread | -3,23 -3,47 6.84% | -5,17 -3,26 -58.89% | -6,06 -5,39 -12.43% | -5,80 -6,34 8.51% | -4,11 -5,75 28.6% | -2,71 -3,77 27.92% | -2,17 -2,75 21.24% | -2,47 -2,18 -13.49% | -2,81 -2,55 -10.18% | -2,65 | -2,90 | -3,20 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,23 -3,46 6.86% | -5,16 -3,25 -58.71% | -6,02 -5,39 -11.75% | -13,0 -6,34 -105.27% | -4,02 -5,75 30.05% | -2,61 -3,77 30.63% | -2,08 -2,75 24.35% | -2,40 -2,18 -10.52% | -2,73 -2,46 -11.05% | -2,57 | -2,84 | -3,09 | ||
|
Net income Million USD | Released Forecast Spread | -3,23 -3,41 5.46% | -5,16 -3,11 -66.22% | -6,02 -5,39 -11.75% | -13,0 -6,34 -105.27% | -4,02 -5,75 30.05% | -2,61 -3,77 30.63% | -2,08 -2,75 24.35% | -2,40 -2,18 -10.52% | ||||||
|
EPS USD | Released Forecast Spread | -4,00 -4,27 6.25% | -6,40 -4,07 -57.38% | -7,40 -6,73 -9.9% | -16,0 -6,40 -150% | -3,60 -5,60 35.71% | -2,00 -3,00 33.33% | -1,60 -2,00 20% | -8,14 -1,60 -408.75% | -1,11 -1,18 5.93% | -0,90 | -0,99 | -0,84 | -0,56 | -0,45 |
| Announcement Date | 12/05/22 | 11/08/22 | 08/11/22 | 30/03/23 | 15/05/23 | 10/08/23 | 13/11/23 | 29/03/24 | 10/05/24 | - | - | - | - | - |
More events
Past sector events for Processa Pharmaceuticals Inc
| 16/05/2024 | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 15:05 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 06:30 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 15/05/2024 12:40 | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 15/05/2024 08:03 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 14/05/2024 22:43 | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 09:52 | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 14/05/2024 06:30 | BAYER AG: Q1 2024 Earnings Release |
